NHC — National Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.37bn
- $1.15bn
- $1.14bn
- 98
- 63
- 66
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 68 | 42 | 139 | 20 | 65.3 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -22.2 | 9.39 | -76.6 | 15.5 | -19.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 7.85 | 120 | -34.4 | -73.3 | 17.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 100 | 203 | 62.4 | 8.74 | 111 |
Capital Expenditures | -26.4 | -21.9 | -39.4 | -30.2 | -27.9 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 12.1 | -42 | -26.5 | 24.2 | 10.3 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -14.3 | -63.9 | -65.9 | -5.98 | -17.6 |
Financing Cash Flow Items | -1.09 | 2.5 | -1.42 | -0.554 | 0.169 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -79.7 | -41.9 | -35.3 | -47.6 | -42.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.09 | 97.5 | -38.8 | -44.9 | 51.1 |